XNAS
SRTA
Market cap386mUSD
Oct 08, Last price
4.47USD
1D
-4.49%
1Q
-12.52%
IPO
-5.50%
Name
Strata Critical Medical Inc
Chart & performance
P/E
9.35
P/S
1.96
EPS
0.48
Div yield, %
—
Shrs. gr., 5y
45.81%
Rev. gr., 5y
53.10%
Revenues
197m
-20.73%
Net income
41m
P
CFO
-49m
L+1,841.80%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Blade Air Mobility, Inc. offers specialized air transport solutions designed to alleviate travel times caused by gridlocked ground routes throughout the United States. The company enables customers to bypass traffic by providing access to both private charter options and individual "by-the-seat" bookings. Its operations utilize a varied fleet, encompassing helicopters, executive jets, propeller-driven turboprops, and amphibious seaplanes. Founded in 2014, Blade Air Mobility is centrally based in New York, New York.
Key people
Chairman of the Board · since 2025
Scott Wunsch
Chief Executive Officer - Trinity · since 2024
Amir Cohen
Chief Accounting Officer · since 2021
Melissa Tomkiel
Co-Chief Executive Officer, General Counsel, Company Secretary, Director · since 2025
Eric Affeldt
Lead Independent Director · since 2025
William Heyburn
Co-Chief Executive Officer, Chief Financial Officer, Head of Corporate Development, Director · since 2025
John Borthwick
Independent Director · since 2023
William Cook
Independent Director · since 2025
Andrew Lauck
Independent Director · since 2023
Kenneth Lerer
Independent Director · since 2021
Independent Director · since 2021
Independent Director · since 2021
Independent Director · since 2019
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2021‑09 | 2020‑09 | 2019‑12 | 2019‑09 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||